Work

Mounting evidence implicates medroxyprogesterone acetate in meningioma risk, but mechanisms require further investigation

Year: 2025

Type: article

Abstract: Brooke C Braman, David R Raleigh; Mounting evidence implicates medroxyprogesterone acetate in meningioma risk, but mechanisms require further investigation

Source: Neuro-Oncology

DOI: 10.1093/neuonc/noaf267

Authors: Brooke C Braman, David R Raleigh

Institution: University of California, San Francisco

Language: English

Topic: Meningioma and schwannoma management

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G5340498288, Understanding druggable drivers of meningioma tumorigenesis, Interplay of tumor genomic and immune characteristics and external drivers of health to improve cancer health outcomes, Chromosomal instability and radiation sensitivity in meningioma, Imaging and Genomic Signatures of Brain Tumor Heterogeneity and Evolution to Optimize Patient Management, Mechanistic and Functional Genomic Interrogation of Meningioma Radiotherapy Response Genes, Brain Tumor SPORE Grant

OpenAlex ID: W4416165356

FWCI: 2.061

Cites: 10

Cited by: 3

Related to: 10